Confronting multidrug-resistant Acinetobacter baumannii: a review

Abstract

Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described. (C) 2010 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.